CD40‐activated B cells contribute to mesothelioma tumor regression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD40‐activated B cells contribute to mesothelioma tumor regression

Published:2010-07-13 Issue:2 Volume:89 Page:255-267
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Jackaman Connie¹,Cornwall Scott²³⁴,Graham Peter Thomas²³⁴,Nelson Delia Jane¹²³⁴

Affiliation:

1. School of Medicine and Pharmacology, Queen Elizabeth II Medical Centre, University of Western Australia Perth Western Australia Australia

2. Immunology and Cancer Group, School of Biomedical Sciences, Curtin University of Technology Perth Western Australia Australia

3. Western Australia Biomedical Research Institute, Curtin University of Technology Perth Western Australia Australia

4. Curtin Health Innovation Research Institute, Curtin University of Technology Perth Western Australia Australia

Funder

Australian Lung Foundation

Western Australian Cancer Council

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/icb.2010.88

Reference53 articles.

1. CD40–CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity

2. CD40 stimulation leads to effective therapy of CD40- tumors through induction of strong systemic cytotoxic T lymphocyte immunity

3. Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation

4. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors;Nowak AK;Cancer Res,2003

5. Vascular targeting of anti-CD40 antibodies and IL-2 into autochthonous tumors enhances immunotherapy in mice

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia;Immunology & Cell Biology;2023-09-11

2. The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model;Frontiers in Immunology;2022-11-18

3. Aging Leads to Increased Monocytes and Macrophages With Altered CSF-1 Receptor Expression and Earlier Tumor-Associated Macrophage Expansion in Murine Mesothelioma;Frontiers in Aging;2022-04-27

4. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities;Nature Reviews Cancer;2022-04-07

5. Developing a translational murine‐to‐canine pathway for an IL ‐2/agonist anti‐CD40 antibody cancer immunotherapy;Veterinary and Comparative Oncology;2022-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3